This investment bank's analyst did a hatchet job on Vertex with his remarks on November second. He actually said in the WSJ that he thinks it is unlikely there was a definite link between the highest dose of VX-809/Kalydeco and improved lung function. Apparently, this investment bank is entitled not just to its own opinion but also its own facts.
Sentiment: Strong Buy